Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,157Revenue $M362Net Margin (%)0Z-Score0
Enterprise Value $M9,157EPS $-2.9Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ONXX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONXXMario Gabelli 2013-09-30 Buy 0.47%$110.99 - $136.03
($126.65)
$ 124.7-2%New holding, 644979 sh.644,979
ONXXPrem Watsa 2013-09-30 Buy 0.04%$110.99 - $136.03
($126.65)
$ 124.7-2%New holding, 4500 sh.4,500
ONXXMariko Gordon 2013-09-30 Sold Out -0.03%$110.99 - $136.03
($126.65)
$ 124.7-2%Sold Out0
ONXXMariko Gordon 2013-06-30 Add0.01%$81.76 - $100.37
($92.06)
$ 124.736%Add 72.04%7,138
ONXXVanguard Health Care Fund 2012-09-30 Reduce-0.1%$64.73 - $85.82
($73.68)
$ 124.769%Reduce -24.4%1,022,700
ONXXGeorge Soros 2011-06-30 Sold Out $33.565 - $45.37
($37.84)
$ 124.7230%Sold Out0
ONXXGeorge Soros 2011-03-31 Add0.06%$34.05 - $37.67
($35.83)
$ 124.7248%Add 1576.09%154,200
ONXXGeorge Soros 2010-12-31 Reduce$25.53 - $37.1
($30.23)
$ 124.7312%Reduce -48.6%9,200
ONXXGeorge Soros 2010-09-30 Buy 0.01%$19.9 - $28.11
($24.97)
$ 124.7399%New holding, 17900 sh.17,900
ONXXVanguard Health Care Fund 2010-06-30 Add0.06%$21.7 - $31.18
($25.78)
$ 124.7384%Add 61.03%1,299,865
ONXXGeorge Soros 2010-03-31 Sold Out $27.76 - $32.46
($30.12)
$ 124.7314%Sold Out0
ONXXGeorge Soros 2009-12-31 Buy $25.13 - $30.04
($27.93)
$ 124.7346%New holding, 11400 sh.11,400
ONXXVanguard Health Care Fund 2009-09-30 Add0.03%$27.23 - $36.55
($31.75)
$ 124.7293%Add 32.94%807,200
ONXXVanguard Health Care Fund 2008-09-30 Buy 0.11%$37.61 - $43.51
($39.8)
$ 124.7213%New holding, 607200 sh.607,200
ONXXJean-Marie Eveillard 2008-09-30 Sold Out -0.02%$37.61 - $43.51
($39.8)
$ 124.7213%Sold Out0
ONXXJean-Marie Eveillard 2008-06-30 Buy 0.02%$33.14 - $36.61
($34.8)
$ 124.7258%New holding, 59300 sh.59,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONXX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ONXX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Torley HelenEVP, Chief Commercial Officer 2013-08-12Sell9,311$126.89-1.73 view
Fust Matthew KEVP & CFO 2013-08-08Sell2,492$128.21-2.74 view
SHEMA SUZANNE MEVP, GC and Corp. Secretary 2013-08-07Sell4,052$131.86-5.43 view
Foster-Cheek Kaye ISVP, Global Human Resources 2013-08-06Sell8,878$132.81-6.11 view
Nevinny Corinne HDirector 2013-07-30Sell1,500$131.26-5 view
GRILLO LOPEZ ANTONIO JDirector 2013-07-30Sell1,500$131.26-5 view
Fust Matthew KEVP & CFO 2013-07-26Sell6,043$130.5-4.44 view
GRILLO LOPEZ ANTONIO JDirector 2013-07-26Sell2,000$130.5-4.44 view
SHEMA SUZANNE MEVP, GC and Corp. Secretary 2013-07-08Sell4,052$135.76-8.15 view
Fust Matthew KEVP & CFO 2013-07-02Sell1,551$132.8-6.1 view

Press Releases about ONXX :

    Quarterly/Annual Reports about ONXX:

      News about ONXX:

      Articles On GuruFocus.com
      Amgen: Stronger Drug Portfolio with Acquisition Sep 22 2014 
      Mario Gabelli Comments on Onyx Pharmaceuticals Inc. Jan 03 2014 
      Columbia Wanger’s Third Quarter Selling Nov 20 2013 
      6 New Stock Picks from Prem Watsa Nov 19 2013 
      Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
      ONYX Pharmaceuticals Inc. (ONXX) EVP & COO Laura Brege sells 12,500 Shares Jan 20 2011 
      ONYX Pharmaceuticals Inc. (ONXX) CFO Matthew K Fust sells 1,812 Shares Jan 07 2011 
      ONYX Pharmaceuticals Inc. (ONXX) President & CEO N Anthony Coles sells 13,669 Shares Dec 08 2010 
      ONYX Pharmaceuticals Inc. (ONXX) EVP & COO Laura Brege sells 25,000 Shares Nov 10 2010 
      ONYX Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 

      More From Other Websites
      Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for... Mar 11 2014
      Amgen 4Q profit leaps 30 percent on higher sales Jan 28 2014
      Amgen 4Q profit leaps 30 percent on higher sales Jan 28 2014
      Amgen Q4 profit leaps 30 percent on higher sales Jan 28 2014
      Amgen Q4 profit leaps 30 percent on higher sales Jan 28 2014
      Best Call of 2013: Onyx Pharmaceuticals Dec 31 2013
      The International Myeloma Foundation Announces Partnership with Onyx Pharmaceuticals to Support... Dec 06 2013
      BioMarin: Where Biotech and Rodney Dangerfield Cross Paths Nov 26 2013
      3 Monday Morning Biotech Movers Nov 25 2013
      2 Biotech Stocks With Strong Buyout Potential Nov 25 2013
      U.S. FDA Approves NEXAVAR® (sorafenib) for the Treatment of Patients with Locally Recurrent or... Nov 22 2013
      Amgen and Onyx Pharmaceuticals Announce Upcoming Data Presentations at 55th American Society of... Nov 07 2013
      Karyopharm Therapeutics IPO Looks Promising Nov 06 2013
      Biotech Stock Bubble Talk Deflated By Cost-Conscious Buyers Oct 02 2013
      ONYX PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Triggering... Oct 01 2013
      Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer Oct 01 2013
      Trade-Ideas: Onyx Pharmaceuticals (ONXX) Is Today's "Water-Logged And Getting Wetter" Stock Sep 30 2013
      ONYX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 24 2013

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK